Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Biotin biosynthesis in Mycobacterium tuberculosis: Physiology, biochemistry and molecular intervention|
|Citation:||Protein and Cell, 2011; 2(9):691-695|
|Publisher:||Gaodeng Jiaoyu Chubanshe|
|Wanisa Salaemae, Al Azhar, Grant W. Booker, Steven W. Polyak|
|Abstract:||Biotin is an important micronutrient that serves as an essential enzyme cofactor. Bacteria obtain biotin either through de novo synthesis or by active uptake from exogenous sources. Mycobacteria are unusual amongst bacteria in that their primary source of biotin is through de novo synthesis. Here we review the importance of biotin biosynthesis in the lifecycle of Mycobacteria. Genetic screens designed to identify key metabolic processes have highlighted a role for the biotin biosynthesis in bacilli growth, infection and survival during the latency phase. These studies help to establish the biotin biosynthetic pathway as a potential drug target for new anti-tuberculosis agents.|
Metabolic Networks and Pathways
|Rights:||© Higher Education Press and Springer-Verlag Berlin Heidelberg 2011|
|Appears in Collections:||Aurora harvest|
Molecular and Biomedical Science publications
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.